Frovatriptan succinate hydrate
Frovatriptan succinate hydrate is a selective 5-HT1B/1D and 5-HT7 receptor agonist used in migraine research. It is effective against acute migraine attacks and associated symptoms, with studies supporting its use for menstrual migraine prophylaxis. Its pharmacological profile makes it a valuable tool for in vitro binding assays and in vivo models of trigeminovascular activation.
Product Specifications
CAS Number
158930-17-7
Product Name Alternative
Carotid, 5-HT1D Receptor, 5-HT1B Receptor, 5-HT1D, 5HT Receptor, 5-HT Receptor, 5-HT1B, 5-hydroxytryptamine Receptor, 5HTReceptor, 5-HT7, (R) -Frovatriptan succinate, Frova, Frovatriptan succinate, Frovatriptan succinate hydrate, Frovatriptan succinate Hydrate, Frovelan, Human 5-HT7 Receptor, menstrual, Inhibitor, nausea, migraine, orally, inhibit, SB 209509 succinate, Serotonin Receptor, phonophobia, photophobia, vascular, vomiting, VML 251 succinate
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.66% (May vary between batches)
Solubility
DMSO:60 mg/mL (158.14 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.27 mM)
Smiles
O.OC (=O) CCC (O) =O.CN[C@@H]1CCc2[nH]c3ccc (cc3c2C1) C (N) =O
Molecular Formula
C18H25N3O6
Molecular Weight
379.41
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
